← Back to Patent Explorer
US5244892A Expired / Lapsed US ⏱️ 0.0 years remaining

Cephem compounds, and antibacterial agents

Assignee: Kyorin Pharmaceutical Co Ltd
•
Filing: 1991-10-11
•
Granted: 1993-09-14
•
Expires: 2011-10-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel cephem compounds represented by a formula [I] and pharmacologically admissible salts or capable of physiologically hydrolyzable nontoxic esters thereof are disclosed. ##STR1## [wherein R 1 indicates a straight-chain or branched lower alkyl group, which may be substituted by carboxyl group which may be protected, trityl group, hydrogen atom or fluorine-substituted lower alkyl group, R 2 indicates a hydrogen atom, metal atom, protective group for carboxyl group or ester residue producible hydrolyzable ester in vivo, R 3 , R 4 , R 5 and R 6 , which may be identical or different, indicate hydrogen atoms, halogen atoms, straight-chain or branched lower alkyl groups, which may be substituted, mercapto groups, which may be substituted, lower alkylamino groups, hydroxyl groups, which may be protected, lower alkoxy groups, lower alkanoyl groups, lower alkoxycarbonyl groups, or lower alkylenedioxy groups, which may be substituted, being maybe formed with R 3 and R 4 , R 7 indicates a hydrogen atom, cyano group, halogen atom or COOR 8 (R 8 is hydrogen or lower alkyl group), R 9 indicates an amino group, which may be protected, Z indicates N or CH, and n indicates 0 or 1]. Preparation processes for them and antibacterial agents containing them as effective ingredients are also claimed.

Inventors

  • 👤 Seigo Suzue
  • 👤 Kikoh Obi
  • 👤 Tatsuhiro Saito
  • 👤 Keiji Hirai
  • 👤 Hideyuki Fukuda

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 00:00
CPC Classifications
C; C07; C07D; C07D501/00; C07D501/14; C07D501/16; C07D501/20; C07D501/24; C07D501/36; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 186 words
A cephem compound represented by formula or a pharmacologically acceptable salt or ester thereof: ##STR141## wherein R 1 indicates a straight-chain or branched lower alkyl group which may be substituted by a carboxyl group or a protected carboxyl group, trityl group, hydrogen atom or fluorine-substituted lower alkyl group, R 2 indicates a hydrogen atom, metal atom or a carboxyl-protective group, R 3 , R 4 , R 5 and R 6 , which may be identical or different, indicate hydrogen atoms, halogen atoms, straight-chain or branched lower alkyl groups which may be substituted with alkoxy, halogen, hydroxyl, protected hydroxyl, amino, alkylamino or acyl, mercapto groups which may be substituted with alkyl, phenyl, 4-methyl-1,2,4-triazole-3-yl or 1-methyltetrazole-5-yl, lower alkylamino groups, hydroxyl groups which may be protected, lower alkoxy groups, lower alkanoyl groups, lower alkoxycarbonyl groups or lower alkylenedioxy group which may be substituted with alkyl, R 7 indicates a hydrogen atom, cyano group, halogen atom or COOR 8 where R 8 is hydrogen or lower alkyl group, R 9 indicates an amino group which may be protected, Z indicates N or CH, and n indicates 0 or 1.
Claim 2
Dependent Claim 186 words
A cephem compound represented by formula or a pharmacologically acceptable salt or ester thereof: ##STR141## wherein R 1 indicates a straight-chain or branched lower alkyl group which may be substituted by a carboxyl group or a protected carboxyl group, trityl group, hydrogen atom or fluorine-substituted lower alkyl group, R 2 indicates a hydrogen atom, metal atom or a carboxyl-protective group, R 3 , R 4 , R 5 and R 6 , which may be identical or different, indicate hydrogen atoms, halogen atoms, straight-chain or branched lower alkyl groups which may be substituted with alkoxy, halogen, hydroxyl, protected hydroxyl, amino, alkylamino or acyl, mercapto groups which may be substituted with alkyl, phenyl, 4-methyl-1,2,4-triazole-3-yl or 1-methyltetrazole-5-yl, lower alkylamino groups, hydroxyl groups which may be protected, lower alkoxy groups, lower alkanoyl groups, lower alkoxycarbonyl groups or lower alkylenedioxy group which may be substituted with alkyl, R 7 indicates a hydrogen atom, cyano group, halogen atom or COOR 8 where R 8 is hydrogen or lower alkyl group, R 9 indicates an amino group which may be protected, Z indicates N or CH, and n indicates 0 or 1.
Claim 3
Dependent Claim 23 words
An antibacterial pharmaceutical composition comprising an effective amount of the compound of claim 1 in admixture with a pharmacologically acceptable carrier or excipient.
Claim 4
Dependent Claim 24 words
A method of treating bacterial infection in a subject which comprises administering to the subject an effective amount of the compound of claim 1.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-09-13 1997-03-15 1997-09-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-09-13 2001-03-15 2001-09-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-09-13 2005-03-15 2005-09-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag